Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Net Income (2016 - 2025)

Veracyte (VCYT) has disclosed Net Income for 14 consecutive years, with $41.2 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 701.75% to $41.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66.4 million through Dec 2025, up 174.78% year-over-year, with the annual reading at $66.4 million for FY2025, 174.89% up from the prior year.
  • Net Income hit $41.2 million in Q4 2025 for Veracyte, up from $19.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $41.2 million in Q4 2025 to a low of -$41.9 million in Q1 2021.
  • Historically, Net Income has averaged -$4.8 million across 5 years, with a median of -$8.2 million in 2023.
  • Biggest five-year swings in Net Income: plummeted 641.71% in 2023 and later soared 701.75% in 2025.
  • Year by year, Net Income stood at -$10.5 million in 2021, then surged by 63.55% to -$3.8 million in 2022, then tumbled by 641.71% to -$28.3 million in 2023, then surged by 118.16% to $5.1 million in 2024, then skyrocketed by 701.75% to $41.2 million in 2025.
  • Business Quant data shows Net Income for VCYT at $41.2 million in Q4 2025, $19.1 million in Q3 2025, and -$950000.0 in Q2 2025.